Raloxifene prevents endothelial dysfunction in aging ovariectomized female rats.

scientific article published on 15 March 2006

Raloxifene prevents endothelial dysfunction in aging ovariectomized female rats. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VPH.2005.12.005
P698PubMed publication ID16542882

P50authorIsmail LaherQ46123583
Paul Michel Georges Remi VanhoutteQ61052529
P2093author name stringXiaoqiang Yao
Yu Huang
Kwok Pui Fung
Chak Leung Au
Chi Ming Wong
Suk Ying Tsang
P2860cites workRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trialQ27860743
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research GroupQ29615228
The Molecular Pharmacology of SERMsQ33730355
Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.Q34177001
Vasomotor and vascular effects of hormone replacement therapyQ34727147
Hyper-reactivity of cerebral arteries from ovariectomized rats: therapeutic benefit of tamoxifenQ35045916
Endothelium-dependent contractions in hypertensionQ35048636
Vascular endothelial dysfunction in aging: loss of Akt-dependent endothelial nitric oxide synthase phosphorylation and partial restoration by (R)-alpha-lipoic acidQ35594359
Postmenopausal oestrogen treatment and stroke: a prospective studyQ35730469
Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosisQ37315678
Endothelial dysfunction and atherosclerosisQ41663978
Gender differences in protein kinase G-mediated vasorelaxation of rat aortaQ43569412
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal womenQ43738095
Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health studyQ43776201
Raloxifene enhances nitric oxide release in rat aorta via increasing endothelial nitric oxide mRNA expressionQ43846868
Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifeneQ43921911
Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide productionQ43974043
Effect of raloxifene on the ovarian circulation in women after menopauseQ43996857
A diffusible substance(s) mediates endothelium-dependent contractions in the aorta of SHR.Q44269039
Characterization of an animal model of postmenopausal hypertension in spontaneously hypertensive ratsQ44353799
Long-term effects of ovariectomy and estrogen replacement treatment on endothelial function in mature ratsQ44485609
Raloxifene, an oestrogen-receptor modulator, prevents decreased constitutive nitric oxide and vasoconstriction in ovariectomized ratsQ73337598
Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal womenQ73911971
Estrogen research. The great estrogen conundrumQ79291883
P433issue5
P921main subjectendotheliumQ111140
P304page(s)290-298
P577publication date2006-03-15
P1433published inVascular PharmacologyQ7916446
P1476titleRaloxifene prevents endothelial dysfunction in aging ovariectomized female rats.
P478volume44

Reverse relations

cites work (P2860)
Q51476885Dehydroepiandrosterone protects against oxidative stress-induced endothelial dysfunction in ovariectomized rats.
Q51321737Effect of raloxifene and atorvastatin in atherosclerotic process in ovariectomized rats.
Q34958259Efficacy of female rat models in translational cardiovascular aging research
Q37698976Endothelial dysfunction and enhanced contractility in microvessels from ovariectomized rats: roles of oxidative stress and perivascular adipose tissue
Q38680112Endothelial dysfunction and vascular disease - a 30th anniversary update
Q35053761Endothelial relaxation mechanisms and oxidative stress are restored by atorvastatin therapy in ovariectomized rats
Q33867587Inhibition of renin-angiotensin system reverses endothelial dysfunction and oxidative stress in estrogen deficient rats
Q89619333Liposomal and Non-Liposomal Formulations of Vitamin C: Comparison of the Antihypertensive and Vascular Modifying Activity in Renovascular Hypertensive Rats
Q36938443Raloxifene protects endothelial cell function against oxidative stress
Q51161046Role of inducible nitric oxide synthase in endothelium-independent relaxation to raloxifene in rat aorta.
Q83765492Simultaneous renal hypertension and type 2 diabetes exacerbate vascular endothelial dysfunction in rats
Q35178316The effects of resveratrol in rats with simultaneous type 2 diabetes and renal hypertension: a study of antihypertensive mechanisms
Q47638875Vascular activation of K+ channels and Na+-K+ ATPase activity of estrogen-deficient female rats.

Search more.